Literature DB >> 15752755

Characterization of mouse myotilin and its promoter.

Luca Mologni1, Monica Moza, Maciej M Lalowski, Olli Carpén.   

Abstract

Myotilin is a sarcomeric protein mutated in two forms of muscle disease, limb-girdle muscular dystrophy type 1A and myofibrillar myopathy. Myotilin is expressed late during human myofibrillogenesis and localizes to Z-discs in mature sarcomere. It interacts with alpha-actinin, actin, and filamin C, and has strong F-actin-bundling activity. These features suggest an important role for myotilin in sarcomere organization. In our effort towards the construction of a genetic model for myotilin-related muscle disorders, we have cloned mouse myotilin, including its promoter region, and studied the expression in various tissues. Mouse myotilin is 90% identical with the human orthologue. Northern blot analysis revealed strong mRNA transcripts in skeletal and cardiac muscle, and weak expression in liver and lung tissue. Western blot and RT-PCR analysis showed the presence of one major product in mouse tissues. Analysis of the 5'-flanking region revealed a number of putative regulatory elements that drive expression in differentiating myoblasts. Finally, endogenous myotilin is induced at later stages of Z-disc assembly in C(2)C(12) cells indicating conservation between mouse and human promoter region.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752755     DOI: 10.1016/j.bbrc.2005.02.074

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Expression of myotilin during chicken development.

Authors:  Dipak K Dube; Jushuo Wang; Christopher Pellenz; Yingli Fan; Syamalima Dube; Mingda Han; Kersti Linask; Jean M Sanger; Joseph W Sanger
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

2.  The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity.

Authors:  Todd J Cohen; Tomasa Barrientos; Zachary C Hartman; Sean M Garvey; Gregory A Cox; Tso-Pang Yao
Journal:  FASEB J       Date:  2008-09-09       Impact factor: 5.191

3.  Identification of novel tissue-specific genes by analysis of microarray databases: a human and mouse model.

Authors:  Yan Song; Jinsoo Ahn; Yeunsu Suh; Michael E Davis; Kichoon Lee
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

4.  Actin nemaline myopathy mouse reproduces disease, suggests other actin disease phenotypes and provides cautionary note on muscle transgene expression.

Authors:  Gianina Ravenscroft; Connie Jackaman; Caroline A Sewry; Elyshia McNamara; Sarah E Squire; Allyson C Potter; John Papadimitriou; Lisa M Griffiths; Anthony J Bakker; Kay E Davies; Nigel G Laing; Kristen J Nowak
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

5.  Protein differences between human trapezius and vastus lateralis muscles determined with a proteomic approach.

Authors:  Jenny Hadrévi; Fredrik Hellström; Thomas Kieselbach; Christer Malm; Fatima Pedrosa-Domellöf
Journal:  BMC Musculoskelet Disord       Date:  2011-08-10       Impact factor: 2.362

6.  Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.

Authors:  Jaakko Sarparanta; Per Harald Jonson; Christelle Golzio; Satu Sandell; Helena Luque; Mark Screen; Kristin McDonald; Jeffrey M Stajich; Ibrahim Mahjneh; Anna Vihola; Olayinka Raheem; Sini Penttilä; Sara Lehtinen; Sanna Huovinen; Johanna Palmio; Giorgio Tasca; Enzo Ricci; Peter Hackman; Michael Hauser; Nicholas Katsanis; Bjarne Udd
Journal:  Nat Genet       Date:  2012-02-26       Impact factor: 38.330

7.  RNAi-mediated Gene Silencing of Mutant Myotilin Improves Myopathy in LGMD1A Mice.

Authors:  Jian Liu; Lindsay M Wallace; Sara E Garwick-Coppens; Darcée D Sloboda; Carol S Davis; Chady H Hakim; Michael A Hauser; Susan V Brooks; Jerry R Mendell; Scott Q Harper
Journal:  Mol Ther Nucleic Acids       Date:  2014-04-29       Impact factor: 10.183

8.  Targeted deletion of the muscular dystrophy gene myotilin does not perturb muscle structure or function in mice.

Authors:  Monica Moza; Luca Mologni; Ras Trokovic; Georgine Faulkner; Juha Partanen; Olli Carpén
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.